ClinicalTrials.Veeva

Menu

Microinterventional Endocapsular Nuclear Fragmentation Assisted Cataract Surgery

O

Oogziekenhuis Rotterdam

Status

Enrolling

Conditions

Nuclear Cataract

Treatments

Device: Lens fragmentation

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05736042
NL83139.078.22 (Other Identifier)
OZR-2022-07

Details and patient eligibility

About

Rationale: In cataract surgery, fragmentation of a hard nucleus requires relatively much ultrasound energy. It is suspected that the level of energy used is associated with the degree of corneal endothelial loss. Recently, it was demonstrated that with miLOOP (Zeiss Meditec) assisted nuclear fragmentation ultrasound energy can be substantially reduced.

Objective: To compare miLOOP assisted cataract surgery and conventional surgery with respect to the energy needed for phacoemulsification and loss of corneal endothelial cells.

Study design: Randomized, controlled trial. Study population: Patients with nuclear cataract of a grade ≥ 5. Intervention: Microinterventional endocapsular nuclear fragmentation. Main study parameters: Cumulative dispersed ultrasound energy (CDE) and endothelial cell loss.

Enrollment

80 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years.
  • Informed consent.
  • Advanced visually significant nuclear sclerosis grade ≥ 5 (LOCS III).

Exclusion criteria

  • Endothelial cell density (ECD) < 1500 mm-2.
  • Corneal opacification (any cause).
  • Corneal surgery or trauma.
  • Implant lens.
  • Refraction surgery.
  • Prior glaucoma surgery.
  • Pseudoexfoliation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups

Lens fragmentation with miLOOP
Experimental group
Description:
Phacoemulsification with adjunctive lens fragmentation with the microinterventional microfilament loop device (miLOOP)
Treatment:
Device: Lens fragmentation
Controls
No Intervention group
Description:
Phacoemulsification alone (no adjunctive lens fragmentation)

Trial contacts and locations

1

Loading...

Central trial contact

Rene Wubbels; Susan Marinissen

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems